ESG
Merck leads Asia-Pacific with sustainable packaging shift
ESG: In a first of its kind initiative for Merck’s Asia-Pacific region, the company has reinforced its commitment to environmental sustainability by directly advancing its SMASH Packaging strategy.
As of September 1, Merck has shifted from traditional expanded polystyrene (EPS) insulation to wool-pack insulation for cold-chain shipments within its Life Science business in Australia.
This transition represents a pivotal change in the company’s packaging approach, replacing 3.6 tons of non-recyclable EPS annually.
“By moving to wool- and fibreboard-based insulation for cold-chain shipments, we offer our customers sustainable packaging solutions without sacrificing our customary one-day transit time,” said Rebecca Lee, Managing Director at Merck Life Science.
“This transition reflects Merck’s dedication to reducing our environmental footprint and promoting a more sustainable value chain.”
The innovative wool-based packaging solution, validated for one-day pharmaceutical shipments under Australia’s intense summer conditions, is produced by Planet Protector Packaging. This new insulation method not only eliminates EPS materials from shipments requiring temperature regulation between 2°C and 8°C but also minimises waste by printing packing labels directly onto the fibreboard boxes, reducing the need for separate labels.
This initiative marks an important step towards systematically improving the sustainability of both new and existing packaging, aligning with Merck’s broader environmental goals.
Merck has defined ambitious goals to be achieved by 2030 and 2040 on its global sustainability strategy, which have been approved by the Science Based Targets initiative in May 2022.
These goals include achieving human progress for over one billion people through sustainable science and technology by 2030, fully integrating sustainability into all value chains by 2030, and achieving climate neutrality and reducing resource consumption by 2040.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Will the new PBS campaign pressure the government to act?
Pharma News: The medicines industry is ramping up its campaign to slash delays in patient access to new and innovative […]
MoreNews & Trends - MedTech & Diagnostics
Private hospitals struggle despite surge in admissions: Financial crisis worsens as inflation outpaces benefits
MedTech & Diagnostics News: Private hospital admissions are on the rise, but this uptick is not enough to counter the […]
MoreDigital & Innovation
Health sector and government under scrutiny: Record data breaches expose millions
Digital & Innovation: The national privacy regulator has raised alarm over escalating threats, reporting a record surge in data breach notifications. […]
MoreMedical and Science
Diabetes research funding plummets by 35%: Consultation launched to reverse decline
Medical & Science: Australia’s diabetes crisis is deepening, with calls for urgent action growing louder. The Standing Committee on Health, […]
More